<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/abel/Downloads/grobid-0.5.6/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">International Journal of Antimicrobial Agents Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2020">2020</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chih-Cheng</forename><surname>Lai</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Internal Medicine</orgName>
								<orgName type="department" key="dep2">Tainan Branch</orgName>
								<orgName type="institution">Kaohsiung Veterans General Hospital</orgName>
								<address>
									<settlement>Tainan</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tzu-Ping</forename><surname>Shih</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Family Medicine</orgName>
								<orgName type="department" key="dep2">Tainan Branch</orgName>
								<orgName type="institution">Kaohsiung Veterans General Hospital</orgName>
								<address>
									<settlement>Tainan</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wen-Chien</forename><surname>Ko</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Medicine</orgName>
								<orgName type="department" key="dep2">College of Medicine</orgName>
								<orgName type="institution">National Cheng Kung University</orgName>
								<address>
									<settlement>Tainan</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hung-Jen</forename><surname>Tang</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">Chi Mei Medical Center</orgName>
								<address>
									<postCode>71004</postCode>
									<settlement>Tainan</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Po-Ren</forename><surname>Hsueh</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Department of Laboratory Medicine</orgName>
								<orgName type="institution" key="instit1">National Taiwan University Hospital</orgName>
								<orgName type="institution" key="instit2">National Taiwan University College of Medicine</orgName>
								<address>
									<settlement>Taipei</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Internal Medicine</orgName>
								<orgName type="institution" key="instit1">National Taiwan University Hospital</orgName>
								<orgName type="institution" key="instit2">National Taiwan University College of Medicine</orgName>
								<address>
									<settlement>Taipei</settlement>
									<country key="TW">Taiwan</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">International Journal of Antimicrobial Agents Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges</title>
					</analytic>
					<monogr>
						<title level="j" type="main">International Journal of Antimicrobial Agents</title>
						<imprint>
							<biblScope unit="volume">55</biblScope>
							<biblScope unit="page">105924</biblScope>
							<date type="published" when="2020">2020</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1016/j.ijantimicag.2020.105924</idno>
					<note type="submission">Article history: Received 11 February 2020 Accepted 12 February 2020 Editor: Jean-Marc Rolain</note>
					<note>Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/ijantimicag a r t i c l e i n f o</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>

		<encodingDesc>
			<appInfo>
				<application version="0.5.6" ident="GROBID" when="2020-03-16T22:29+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>		<profileDesc>
			<textClass>
				<keywords>2019-nCoV SARS-CoV-2 COVID-19 China Epidemic Remdesivir</keywords>
			</textClass>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p>Since the emergence of the 2019 novel coronavirus (2019-nCoV) infection in Wuhan, China, in December 2019 <ref type="bibr" target="#b0">[1]</ref> , it has rapidly spread across China and many other countries <ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref> . So far, 2019-nCoV has affected more than 43 0 0 0 patients in 28 countries/regions and has became a major global health concern ( https: //www.who.int/docs/default-source/coronaviruse/situation-reports/ 20200211-sitrep-22-ncov.pdf?sfvrsn=6f80d1b9 _ 4 ). On 11 February 2020, the World Health Organization (WHO) announced a new for a pandemic <ref type="bibr">[5 , 10 , 13]</ref> . In addition to the high transmission efficiency of SARS-CoV-2, the advancement and convenience of global travel could further enhance its worldwide spread <ref type="bibr" target="#b11">[12]</ref> . On 30 January 2020, the WHO declared the COVID-19 outbreak as the sixth public health emergency of international concern, following H1N1 (2009), polio (2014), Ebola in West Africa (2014), Zika <ref type="bibr">(2016)</ref> and Ebola in the Democratic Republic of Congo (2019). Therefore, health workers, governments and the public need to co-operate globally to prevent its spread <ref type="bibr" target="#b13">[14]</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">SARS-CoV-2 and COVID-19</head><p>In addition to seasonal influenza, reported pathogens of pneumonia include adenovirus, coronavirus 229E/NL63/OC43, human bocavirus, human metapneumovirus, parainfluenza virus 1/2/3, rhinovirus and respiratory syncytial virus A/B <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref> . Moreover, these viruses can cause co-infection in the setting of communityacquired bacterial pneumonia <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref> . Using molecular methods, knowledge about the role of these viruses in the setting of pneumonia has achieved significant advancements <ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref> . SARS-CoV-2 was found to be a positive-sense, single-stranded RNA virus belonging to the genus Betacoronavirus <ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref> . Phylogenetic analysis revealed that SARS-CoV-2 is closely related (88-89% similarity) to two bat-derived SARS-like coronaviruses, namely bat-SL-CoVZC45 (GenBank accession no. MG772933.1 ) and bat-SL-CoVZXC21 (GenBank accession no. MG772934.1 ), but it is more distant from SARS-CoV (~79% similarity) and Middle East respiratory syndrome coronavirus (MERS-CoV) (~50% similarity) <ref type="bibr">[23 , 25 , 26]</ref> . Chen et al . applied an RNA-based metagenomic nextgeneration sequencing approach to identify a human coronavirus from two pneumonia cases during the Wuhan outbreak in 2019 <ref type="bibr" target="#b26">[27]</ref> . Its entire genome was 29 881 bp in length <ref type="bibr" target="#b26">[27]</ref> . Phylogenetic analysis indicates that SARS-CoV-2 is similar to the coronavirus circulating in Rhinolophus (horseshoe bats), with 98.7% nucleotide similarity to the partial RNA-dependent RNA polymerase ( RdRp ) gene of the bat coronavirus strain BtCoV/4991 (GenBank KP876546 , 370 bp sequence of RdRp ) and 87.9% nucleotide similarity to bat coronavirus strain bat-SL-CoVZC45 and bat-SL-CoVZXC21. Evolutionary analysis based on ORF1a/1b, S and N genes suggests that SARS-CoV-2 is more likely a novel coronavirus that was independently introduced from animals to humans <ref type="bibr" target="#b26">[27]</ref> . Based on the findings of genomic investigations and the presence of some bats and live animals in the seafood market in Wuhan, SARS-CoV-2 may have originated from bats or bat droppings associated with contaminated materials in the market or surrounding region <ref type="bibr">[25 , 28]</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Epidemiology</head><p>Based on observations of data from the early outbreak in mainland China from 10-24 January 2020, the trend of an increasing incidence largely follows exponential growth, and the mean basic reproduction number ( R 0 ) was estimated to range from 2.24 [95% confidence interval (CI) 1.96-2.55] to 3.58 (95% CI 2.89-4.39), associated with two-to eight-fold increases in the reporting rate <ref type="bibr" target="#b10">[11]</ref> . Another estimation based on data from 31 December 2019 to 28 January 2020 suggested similar findings, with the R 0 for COVID-19 being 2.68 [95% credible interval (CrI) 2.47-2.86] and the epidemic doubling time being 6.4 days (95% CrI 5.8-7.1 days) <ref type="bibr" target="#b28">[29]</ref> . The current estimate of the mean incubation period for COVID-19 is 6.4 days, ranging from 2.1 days to 11.1 days (2.5th to 97.5th percentile) <ref type="bibr" target="#b29">[30]</ref> , with potential asymptomatic transmission. Although the situation is evolving and further updated data are required to confirm these estimations, there is great potential for a large outbreak of COVID-19 soon.</p><p>As of 11 February 2020, data from the WHO showed that there were a total of 43 103 cases of COVID-19 ( Figs 1 and 2 ) ( https: //www.who.int/docs/default-source/coronaviruse/situation-reports/ 20200211-sitrep-22-ncov.pdf?sfvrsn=6f80d1b9 _ 4 ). There has been a steady rise in the daily total number of COVID-19 cases globally, both within and outside China <ref type="figure" target="#fig_0">( Fig. 1 )</ref>. Regarding new cases of COVID-19, a declining trend was found globally <ref type="figure">( Fig. 2 A)</ref>, in China but not outside China <ref type="figure">( Fig. 2 B)</ref>, mainly in international conveyance (Japan) on 11 February 2020. Twenty-eight countries/regions have reported confirmed cases, including mainland China, Japan, Singapore, Hong Kong Special Administrative Region (SAR), Thailand, South Korea, Taiwan, Australia, Malaysia, Germany, Vietnam, the USA, Macao SAR, the United Arab Emirates, Canada, France, the Philippines, the UK, Italy, India, Russia, Finland, Sweden, Sri Lanka, Cambodia, Nepal, Spain and Belgium. China has had the largest number of patients with COVID-19 ( n = 42 690), followed by Singapore ( n = 45) <ref type="figure" target="#fig_2">( Fig. 3 A)</ref>. Asia has had most of the reported cases, followed by Europe, North America and Australia, but no cases have been reported in Africa. Within China, Hubei has endured the largest number of infected patients ( n = 31 728), followed by Guangdong ( n = 1177), Zhejiang ( n = 1117) and Henan ( n = 1105) <ref type="figure" target="#fig_2">( Fig. 3 B)</ref>. A total of 1017 mortalities have been reported globally, with only 2 mortalities occurring outside of mainland China, one each in Hong Kong SAR and the Philippines. According to the Taiwan Centers for Disease Control ( https://www.cdc.gov.tw/En ), as of 12 February 2020 there were 45 167 cases of COVID-19 reported from 28 countries/region and 1115 (2.5%) of patients had died. Among the 45 167 cases, most were found in mainland China ( n = 44 653) and the reported mortality was 2.5% ( n = 1113).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Clinical manifestations</head><p>As of 10 February 2020, only three relatively large-scale case studies have thoroughly demonstrated the clinical features of patients with pneumonia caused by SARS-CoV-2 (SARS-CoV-2 pneumonia) in Wuhan <ref type="bibr">[4 , 5 , 8]</ref> . Herein, we summarise the clinical manifestations of the 278 pooled patients with SARS-CoV-2 pneumonia, which is also referred to as novel coronavirus pneumonia or Wuhan pneumonia ( <ref type="table" target="#tab_1">Table 1 )</ref>. All of the patients were adults older than 18 years of age, and males comprised 61.9% of the patients ( n = 172). A recent study in Beijing reported that 2 of the 13 patients with SARS-CoV-2 pneumonia were children aged between 2-15 years <ref type="bibr" target="#b8">[9]</ref> . As of 10 February 2020, more than 20 paediatric cases have been reported in China, 10 of whom were identified in Zhejiang Province and were in the age range of 112 days to 17 years <ref type="bibr" target="#b30">[31]</ref> . Among adult patients, cardiovascular disease and hypertension were the most common underlying diseases, followed by diabetes mellitus. Fever was the most common symptom (92.8%; n = 258), followed by cough (69.8%; n = 194), dyspnoea (34.5%; n = 96), myalgia (27.7%; n = 77), headache (7.2%; n = 20) and diarrhoea (6.1%; n = 17). Rhinorrhoea was noted in only 4.0% <ref type="bibr" target="#b3">[4]</ref> , a sore throat in 5.1% <ref type="bibr" target="#b3">[4]</ref> and pharyngalgia in 17.4% <ref type="bibr" target="#b7">[8]</ref> of patients with relevant clinical information. Most patients had a normal white blood cell count, but 56.8% ( n = 158) of patients had leukopenia. In one study, patients requiring intensive care were significantly older and more likely to have underlying diseases <ref type="bibr" target="#b7">[8]</ref> , but another study showed different findings <ref type="bibr" target="#b4">[5]</ref> . According to two studies, patients admitted to the intensive care unit (ICU) were more likely to have dyspnoea than non-ICU patients <ref type="bibr">[5 , 8]</ref> . Among the 13 patients with SARS-CoV-2 pneumonia reported in Beijing, 12 (92.3%) had fever with a mean duration of 1.6 days before hospitalisation <ref type="bibr" target="#b8">[9]</ref> . Other symptoms included cough (46.3%), upper airway congestion (61.5%), myalgia (23.1%) and headache (23.1%) <ref type="bibr" target="#b8">[9]</ref> . Although some of the epidemiological characteristics were identified, considerable uncertainties are still present and additional studies are needed with detailed information from confirmed cases <ref type="bibr" target="#b31">[32]</ref> . </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Imaging</head><p>Radiological findings of SARS-CoV-2 pneumonia are variable. More than 75% of patients presented with bilateral lung involvement <ref type="bibr">[4 , 5 , 8 , 32]</ref> , and multilobe involvement was also common (71%) <ref type="bibr" target="#b32">[33]</ref> . Ground-glass opacity (GGO) was the most common finding from chest computed tomography (CT) <ref type="bibr">[8 , 34]</ref> , and in a series of 21 patients, 86% had GGO on chest CT and 29% showed consolidation <ref type="bibr" target="#b32">[33]</ref> . Approximately one-third of patients showed a peripheral distribution of GGO. In contrast, no discrete nodules, cavitation, pleural effusion or lymphadenopathy were observed on the chest CT images <ref type="bibr">[33 , 34]</ref> . Another study including 51 cases showed similar findings <ref type="bibr" target="#b34">[35]</ref> : most CT images showed pure GGO (77%), followed by GGO with reticular and/or interlobular septal thickening (75%), GGO with consolidation (59%) and pure consolidation (55%). Of the 51 cases, 86% showed bilateral lung involvement, and the above findings were peripherally distributed in 86% of cases <ref type="bibr" target="#b34">[35]</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.">Potential treatment options</head><p>According to recent reports <ref type="bibr">[4 , 5 , 8]</ref> , &gt; 85% of patients received antiviral agents, including oseltamivir (75 mg every 12 h orally), ganciclovir (0.25 g every 12 h intravenously) and lopinavir/ritonavir tablets (40 0/10 0 mg twice daily orally). Empirical antibiotics were prescribed for 90% of patients in three reports <ref type="bibr">[4 , 5 , 8]</ref> , and according to one study 15 patients (15%) received antifungal agents <ref type="bibr" target="#b3">[4]</ref> . Five cases (5.1%) of bacterial ( n = 1) or Candida ( n = 4) coinfections were reported among 99 patients in one study <ref type="bibr" target="#b3">[4]</ref> , and 4 cases (9.8%) of secondary bacterial infections were reported in another study of 41 patients <ref type="bibr" target="#b4">[5]</ref> ( <ref type="table" target="#tab_2">Table 2 )</ref>. Although intravenous immunoglobulin and systemic steroids have been used in several reports <ref type="bibr">[4 , 5 , 8]</ref> , their efficacy and associated adverse effects remain unclear. So far, there has been no effective treatment of COVID-19. Several potential drug candidates, including lopinavir/ritonavir (Kaletra R ), nucleoside analogues, neuraminidase inhibitors, remdesivir, umifenovir (Arbidol R ), DNA synthesis inhibitors (such as tenofovir disoproxil and lamivudine), chloroquine and Chinese traditional medicines (such as ShuFeng JieDu or Lianhua Qingwen capsules), have been proposed <ref type="bibr">[36 , 37]</ref> . In addition, an angiotensin-converting enzyme 2 (ACE2)-based peptide, 3CLpro inhibitor (3CLpro-1) and a novel vinylsulfone protease inhibitor, theoretically, appear to show potential for antiviral activity against SARS-CoV-2 <ref type="bibr" target="#b38">[38]</ref> . Chloroquine has been well described with in vitro effects on inhibition of uncoating and/or alteration of posttranslational modifications of newly synthesised proteins, especially inhibition of glycosylation in many viruses, including human immunodeficiency virus (HIV) <ref type="bibr" target="#b39">[39]</ref> . Preliminary in vivo clinical studies suggest that chloroquine alone or in combination</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Color</head><p>Case no.     with antiretroviral agents might play an interesting role in treating HIV infection <ref type="bibr" target="#b39">[39]</ref> . A recent study by Wang et al. revealed that remdesivir and chloroquine were highly effective in the control of 2019-nCoV in vitro <ref type="bibr" target="#b37">[37]</ref> . In addition to the one case of SARS-CoV-2 pneumonia with a promising clinical response to remdesivir <ref type="bibr" target="#b6">[7]</ref> and two clinical trials in China, further case-controlled clinical studies of remdesivir therapy are warranted to verify its therapeutic efficacy.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="7.">Outcomes</head><p>In the three pooled studies of 278 patients <ref type="bibr">[4 , 5 , 8]</ref> , 72 patients (25.9%) with SARS-CoV-2 pneumonia required ICU admission, 56 (20.1%) developed acute respiratory distress syndrome, and 23 (8.3%) and 9 (3.2%) required invasive mechanical ventilation and extracorporeal membrane oxygenation for refractory hypoxemia, respectively ( <ref type="table" target="#tab_2">Table 2</ref> ). Shock was observed in 19 patients (6.8%), acute kidney injury in 11 patients (4.0%) and continuous renal replacement therapy was required in 14 patients (5.0%). Acute cardiac injury was reported in 5 patients (12.2%) in one study <ref type="bibr" target="#b4">[5]</ref> and 10 patients (7.2%) in another study <ref type="bibr" target="#b7">[8]</ref> . Although two earlier studies demonstrated that SARS-CoV-2 pneumonia was associated with high mortality rates of 11.1% ( n = 11) [4] and 14.6% ( n = 6) <ref type="bibr" target="#b4">[5]</ref> , one recent study showed a mortality rate of 4.3% ( n = 6) [8] ( <ref type="table" target="#tab_2">Table 2 )</ref>. Among 13 patients with SARS-CoV-2 pneumonia outside of Wuhan, as of 4 February 2020 all of the patients recovered but 12 were still being quarantined in hospital in Beijing <ref type="bibr" target="#b8">[9]</ref> . It might be suggested that the real-world mortality rate may be lower than that reported in a few published clinical series, when clinical data from more systematic testing would be available, and as the ratio between fatality cases and total reported cases of COVID-19 on 12 February 2020 was currently 0.025 (mortality rate 2.5%). However, most deaths developed in male and elderly patients <ref type="bibr">[4 , 40]</ref> . The median number of days from the appearance of the first symptom to death was 14 days, and it was significantly shorter among patients aged ≥70 years (11.5 days) compared with those aged &lt; 70 years (20 days) ( P = 0.033) <ref type="bibr" target="#b40">[40]</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.">Infection control and prevention</head><p>To decrease the damage associated with COVID-19, public health and infection control measures are urgently required to limit the global spread of the virus <ref type="bibr" target="#b34">[35]</ref> . Experience from the early phase of SARS-CoV-2 pneumonia strongly highlighted that travel history, rather than chest radiography, is of paramount importance for early detection and isolation of SARS-CoV-2 pneumonia cases <ref type="bibr" target="#b41">[41]</ref> . It is essential to limit human-to-human transmission in order to reduce secondary infections among close contacts and healthcare workers and to prevent transmission amplification events and further international spread from China. Based on previous experience of management of MERS and SARS infections, the WHO recommend infection control interventions to reduce the general risk of transmission of acute respiratory infections, including avoiding close contact with people suffering from acute respiratory infections, frequent hand-washing especially after direct contact with ill people or their environment, and avoiding unprotected contact with farm or wild animals. Moreover, people with symptoms of acute respiratory infection should practice cough etiquette, which is to maintain distance, cover coughs and sneezes with disposable tissues or clothing, and wash hands, and within healthcare facilities enhanced standard infection prevention and control practices are recommended in hospitals, especially in emergency departments <ref type="bibr" target="#b42">[42]</ref> . The US Centers for Disease Control and Prevention (CDC) has established interim clinical guidance for the COVID-19 outbreak to implement aggressive measures to slow the transmission of SARS-CoV-2 in the USA <ref type="bibr" target="#b43">[43]</ref> . These measures include identification of cases and their contacts in the USA as well as appropriate assessment and care of travellers arriving from mainland China to the USA <ref type="bibr" target="#b43">[43]</ref> . All effort s are being made to slow the spread of the illness in order to provide time to better prepare healthcare systems and the general public, to better characterise COVID-19 to guide public-health recommendations, and to develop timely diagnostics, therapeutics and vaccines <ref type="bibr" target="#b43">[43]</ref> . Finally, although the improvement of internet communication largely enhances the availability and dissemination of knowledge, the internet also has the potential for the development and spread of misinformation or fake news. Governments should be responsible for providing accurate knowledge and clarifying misinformation to help the public face this novel infection.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.">Unresolved issues</head><p>Despite the whole world's effort s to underst and COVID-19, many issues remain unclear. First, one report has demonstrated the presence of SARS-CoV-2 in patient stools <ref type="bibr" target="#b6">[7]</ref> . However, whether SARS-CoV-2 can be transmitted through the faecal-oral route remains unclear. Second, previous studies showed that SARS-CoV and other coronaviruses could survive on environmental surfaces and inanimate objects <ref type="bibr">[44 , 45]</ref> ; however, the presence of SARS-CoV-2 in the environment has not been reported. Previous studies have shown that coronaviruses could be efficiently inactivated using surface disinfectants with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 min, but other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate were less effective <ref type="bibr" target="#b45">[45]</ref> . However, current investigation of the efficacy of commonly used disinfection agents against SARS-CoV-2 is lacking. Third, although travel restriction was exerted in many countries, whether this intervention was effective is unclear. Fourth, although one case responded well to remdesivir <ref type="bibr" target="#b6">[7]</ref> and one in vitro study <ref type="bibr" target="#b37">[37]</ref> showed that remdesivir and chloroquine were promising for the treatment of COVID-19, further clinical trials on the effectiveness of remdesivir and chloroquine for treating SARS-CoV-2 pneumonia should be conducted. Fifth, although several studies have reported the clinical features of COVID-19 <ref type="bibr">[4 , 5 , 8 , 9]</ref> , all of the patients had pneumonia and were treated in Wuhan and Beijing. Most recently, an article has described 1099 patients with acute respiratory disease (ARD) caused by SARS-CoV-2 treated at 552 hospitals across 31 provinces/provincial municipalities in China <ref type="bibr" target="#b46">[46]</ref> . The article reported that only 43.8% of patients had a initial presentation of fever, and severe pneumonia occurred in 15.7% of cases. The study indicated the median incubation period to be 3.0 days (range, 0-24.0 days) and the fatality rate to be only 1.36% <ref type="bibr" target="#b46">[46]</ref> . However, further evaluation of the content of the above report is warranted to clarify the epidemiological and clinical characteristics of asymptomatic carriers and of ARD and pneumonia caused by SARS-CoV-2. Finally, although 32.4% ( n = 90) of the reported 278 cases with SARS-CoV-2 pneumonia received systemic steroid therapy <ref type="bibr">[4 , 5 , 8]</ref> , a study on the temporal features of the SARS-CoV-2-induced inflammatory response in relation to the timing of therapeutic interventions is lacking. Previous experiences of systemic steroids in the treatment of coronavirus-related infections, such as SARS and MERS, showed disappointing results. In the interim, clinical use of glucocorticoids to control SARS-CoV-2 pneumonia with the intention of regulating cytokine production and the inflammatory response and avoiding lung injury should be avoided <ref type="bibr">[47 , 48]</ref> .</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.">Conclusions</head><p>The outbreak of COVID-19 has become a clinical threat to the general population and healthcare workers worldwide. However, knowledge about this novel virus remains limited. The effective option of antiviral therapy and vaccination are currently under evaluation and development. What we can do now is aggressively implement infection control measures to prevent the spread of SARS-CoV-2 via human-to-human transmission. Public health authorities should keep monitoring the situation, as the more we learn about this novel virus and its associated outbreaks, the better we can respond.</p><p>Funding: None.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc>Jan 22-Jan 23-Jan 24-Jan 25-Jan 26-Jan 27-Jan 28-Jan 29-Jan 30-Jan 31-Jan 1-Feb 2-Feb 3-Feb 4-Feb 5-Feb 6-Feb 7-Feb 8-Feb 9-Feb 10-Feb 11Daily accumulative cases of laboratory-confirmed cases of 2019 coronavirus disease (COVID-19) as of 11 February 2020: (A) daily numbers of global cases; and (B) daily numbers of cases from China [including Hong Kong Special Administrative Region (SAR) and Macau SAR] and outside of China.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>-Feb 2 -Feb 3 -Feb 4 -Feb 5 -Feb 6 -Feb 7 -Feb 8 -Fig. 2 .</head><label>23456782</label><figDesc>23-Jan 24-Jan 25-Jan 26-Jan 27-Jan 28-Jan 29-Jan 30-Jan 31-Jan 1Feb New daily cases of laboratory-confirmed 2019 coronavirus disease (COVID-19) as of 11 February 2020: (A) daily numbers of new cases globally; and (B) daily numbers of new cases from China [including Hong Kong Special Administrative Region (SAR) and Macau SAR] and outside of China.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3 .</head><label>3</label><figDesc>Distribution of laboratory-confirmed cases of 2019 coronavirus disease (COVID-19) (A) globally by country and (B) in China by province/region as of 11 February 2020.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc>not available; ARDS, acute respiratory distress syndrome; aPTT, activated partial thromboplastin time; PT, prothrombin time; ALT, alanine aminotransferase; AST, aspartate aminotransferase. a Data are n (%), n / N (%), mean (standard deviation) or median (interquartile range).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1" validated="true"><head>Table 1</head><label>1</label><figDesc>Demographic data, underlying medical conditions, clinical manifestations and laboratory findings from three studies of 278 patients with SARS-CoV-2 pneumonia in Wuhan,</figDesc><table>China [4 , 5 , 8] a . 

Huang et al. [5] ( n = 41) 
Chen et al. [4] ( n = 99) 
Wang et al. [8] ( n = 138) 

Study site 
Wuhan local health authority 
Wuhan Jinyintan Hospital 
Zhongnan Hospital of Wuhan University 
Age (years) 
49 (41-58) 
55.5 (13.1) 
56 (42-68) 
≥65 years 
6 (14.6) 
NA 
NA 
Sex 
Male 
30 (73.2) 
67 (67.7) 
75 (54.3) 
Female 
11 (26.8) 
32 (32.3) 
63 (45.7) 
Presumed hospital-related infection 
NA 
NA 
57 (41.3) 
Healthcare worker 
NA 
NA 
40 (29.0) 
Any co-morbidity 
13 (31.7) 
50 (51.5) 
64 (46.4) 
Co-morbidities 
Cardiovascular disease 
6 (14.6) 
40 (40.4) 
20 (14.5) 
Hypertension 
6 (14.6) 
NA 
43 (31.2) 
Diabetes 
8 (19.5) 
12 (12.1) 
14 (10.1) 
Respiratory disease 
1 (2.4) 
1 (1.0) 
4 (2.9) 
Malignancy 
1 (2.4) 
1 (1.0) 
10 (7.2) 
Chronic kidney disease 
NA 
NA 
4 (2.9) 
Chronic liver disease 
1 (2.4) 
NA 
4 (2.9) 
Symptoms and signs 
Fever 
40 (97.6) 
82 (82.8) 
136 (98.6) 
Cough 
31 (75.6) 
81 (81.8) 
82 (59.4) 
Dyspnoea 
22/40 (55.0) 
31 (31.3) 
43 (31.2) 
Sputum production 
11/38 (28.9) 
37 (26.8) 
Myalgia 
18 (43.9) 
11 (11.1) 
48 (34.8) 
Headache 
3/38 (7.9) 
8 (8.1) 
9 (6.5) 
Diarrhoea 
1/38 (2.6) 
2 (2.0) 
14 (10.1) 
Rhinorrhoea 
NA 
4 (4.0) 
NA 
Sore throat or pharyngalgia 
NA 
5 (5.1) 
24 (17.4) 
Duration of onset to dyspnoea 
8 (5-13) 
</table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2" validated="false"><head>Table 2 Treatment</head><label>2</label><figDesc></figDesc><table>and outcomes of 278 patients with SARS-CoV-2 pneumonia in Wuhan, China [4 , 5 , 8] . 

Huang et al. [5] ( n = 41) 
Chen et al. [4] ( n = 99) 
Wang et al. [8] ( n = 138) 

Treatment 
Antiviral treatment 
38 (92.7) 
75 (75.8) 
124 (89.9) 
Antibiotic treatment 
41 (100) 
70 (70.7) 
138 (100) 
Antifungal treatment 
NA 
15 (15.2) 
NA 
Corticosteroid treatment 
9 (22.0) 
19 (19.2) 
62 (44.9) 
CRRT 
3 (7.3) 
9 (9.1) 
2 (1.4) 
IVIg therapy 
NA 
27 (27.3) 
NA 
Invasive mechanical ventilation 
2 (4.9) 
4 (4.0) 
17 (12.3) 
ECMO 
2 (4.9) 
3 (3.0) 
4 (2.9) 
Complications 
ARDS 
12 (29.3) 
17 (17.2) 
27 (19.6) 
Acute kidney injury 
3 (7.3) 
3 (3.0) 
5 (3.6) 
Acute cardiac injury 
5 (12.2) 
NA 
10 (7.2) 
Co-or secondary infection 
4 (9.8) 
5 (5.1) 
NA 
Shock 
3 (7.3) 
4 (4.0) 
12 (8.7) 
ICU unit admission 
13 (31.7) 
23 (23.2) 
36 (26.1) 
Mortality 
6 (14.6) 
11 (11.1) 
6 (4.3) 

CRRT, continuous renal replacement therapy; IVIg, intravenous immunoglobulin; ECMO, extracorporeal membrane oxygena-
tion; ARDS, acute respiratory distress syndrome; NA, not available; ICU, intensive care unit. 
a Data are number (%) of confirmed patients. 
</table></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Competing interests: None declared.</head><p>Ethical approval: Not required.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">W</forename><surname>Stratton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">W</forename><surname>Tang</surname></persName>
		</author>
		<idno type="DOI">10.1002/jmv.25678</idno>
	</analytic>
	<monogr>
		<title level="j">J Med Virol</title>
		<imprint>
			<date type="published" when="2020-01-16" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Tong</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa2001316</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<date type="published" when="2020-01-29" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Severe acute respiratory syndrome-related coronavirus: the species and its viruses-a statement of the Coronavirus Study Group</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">E</forename><surname>Gorbalenya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">C</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">S</forename><surname>Baric</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">J</forename><surname>De Groot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Drosten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">A</forename><surname>Gulyaeva</surname></persName>
		</author>
		<idno type="DOI">10.1101/2020.02.07.937862</idno>
		<imprint>
			<date type="published" when="2020-02-11" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Gong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Han</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(20)30211-7</idno>
		<idno>doi: 10.1016/ S0140-6736(20</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">395</biblScope>
			<biblScope unit="page" from="30211" to="30218" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Hu</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(20)30183-5</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">395</biblScope>
			<biblScope unit="page" from="497" to="506" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">A novel coronavirus outbreak of global health concern</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">W</forename><surname>Horby</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">G</forename><surname>Hayden</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">F</forename><surname>Gao</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(20)30185-9</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">395</biblScope>
			<biblScope unit="page" from="30185" to="30194" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">First case of 2019 novel coronavirus in the United States</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">L</forename><surname>Holshue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Debolt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Lindquist</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Lofy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Wiesman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Bruce</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa2001191</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<date type="published" when="2020-01-31" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2020.1585</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<date type="published" when="2020-02-07" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dela</forename><surname>Cruz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename></persName>
		</author>
		<idno type="DOI">10.1001/jama.2020.1623</idno>
		<idno>doi: 10.1001/ jama.2020.1623</idno>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<date type="published" when="2020-02-07" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Novel Wuhan (2019-nCoV) coronavirus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">G</forename><surname>Carlos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dela</forename><surname>Cruz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Pasnick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Jamil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename></persName>
		</author>
		<idno type="DOI">10.1164/rccm.2014P7</idno>
		<idno>doi: 10.1164/ rccm.2014P7</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">201</biblScope>
			<biblScope unit="page" from="7" to="8" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Ran</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">S</forename><surname>Musa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijid.2020.01.050</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="214" to="231" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The next big threat to global health?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Biscayart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Angeleri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Lloveras</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Chaves</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Schlagenhauf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Rodriguez-Morales</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tmaid.2020.101567</idno>
	</analytic>
	<monogr>
		<title level="m">What advice can we give to travellers? -Interim recommendations</title>
		<imprint>
			<date type="published" when="2019-01" />
			<biblScope unit="volume">2020</biblScope>
			<biblScope unit="page">101567</biblScope>
		</imprint>
	</monogr>
	<note>American Society for Travel Medicine (SLAMVI)</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">A novel coronavirus emerging in China-key questions for impact assessment</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">J</forename><surname>Munster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Koopmans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Van Doremalen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Van Riel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>De Wit</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMp2000929</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<date type="published" when="2020-01-24" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The fight against the 2019-nCoV outbreak: an arduous march has just begun</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Yoo</surname></persName>
		</author>
		<idno type="DOI">10.3346/jkms.2020.35.e56</idno>
	</analytic>
	<monogr>
		<title level="j">J Korean Med Sci</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page">56</biblScope>
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">G</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">E</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>La</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Han</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jmii.2019.05.007</idno>
	</analytic>
	<monogr>
		<title level="j">J Microbiol Immunol Infect</title>
		<imprint>
			<date type="published" when="2019-06-19" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Recommendations and guidelines for the treatment of pneumonia in Taiwan</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">F</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">S</forename><surname>Chang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jmii.2018.11.004</idno>
	</analytic>
	<monogr>
		<title level="j">J Microbiol Immunol Infect</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="172" to="99" />
			<date type="published" when="2019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Community-acquired adenoviral and pneumococcal pneumonia complicated by pulmonary aspergillosis in an immunocompetent adult</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">T</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">C</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">T</forename><surname>Cia</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jmii.2019.05.014</idno>
	</analytic>
	<monogr>
		<title level="j">J Microbiol Immunol Infect</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="838" to="847" />
			<date type="published" when="2019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Severe communityacquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">C</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">C</forename><surname>Chuang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jmii.2018.05.007</idno>
	</analytic>
	<monogr>
		<title level="j">J Microbiol Immunol Infect</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="365" to="371" />
			<date type="published" when="2019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">Y</forename><surname>Ruan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">C</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">F</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Y</forename><surname>Chien</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">R</forename><surname>Hsueh</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jmii.2019.10.009</idno>
	</analytic>
	<monogr>
		<title level="j">J Microbiol Immunol Infect</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="920" to="928" />
			<date type="published" when="2019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Molecular epidemiology and clinical features of rhinovirus infections among hospitalized patients in a medical center in Taiwan</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">M</forename><surname>Hung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">H</forename><surname>Chiu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">Y</forename><surname>Kuo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">A</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jmii.2018.08.009</idno>
	</analytic>
	<monogr>
		<title level="j">J Microbiol Immunol Infect</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="233" to="274" />
			<date type="published" when="2019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Molecular epidemiology and clinical features of adenovirus infection in Taiwanese children</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">L</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">Y</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">I</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">Y</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">C</forename><surname>Weng</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jmii.2018.07.005</idno>
	</analytic>
	<monogr>
		<title level="j">J Microbiol Immunol Infect</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="215" to="239" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Kok</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">K</forename><surname>To</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Yuan</surname></persName>
		</author>
		<idno type="DOI">10.1080/22221751.2020.1719902</idno>
	</analytic>
	<monogr>
		<title level="j">Emerg Microbes Infect</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="221" to="257" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Niu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(20)30251-8</idno>
		<idno>doi: 10.1016/ S0140-6736</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="30251" to="30259" />
			<date type="published" when="2020-01-30" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">A novel coronavirus from patients with pneumonia in China</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Song</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa2001017</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<date type="published" when="2019" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Shi</surname></persName>
		</author>
		<idno type="DOI">10.1080/22221751.2020.1723441</idno>
	</analytic>
	<monogr>
		<title level="j">Emerg Microbes Infect</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="275" to="282" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">L</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">Q</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">C</forename><surname>Xiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1097/CM9.0000000000000722</idno>
	</analytic>
	<monogr>
		<title level="j">Chin Med J (Engl</title>
		<imprint>
			<date type="published" when="2020-01-30" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1080/22221751.2020.1725399</idno>
		<idno>doi: 10.1080/ 22221751.2020.1725399</idno>
	</analytic>
	<monogr>
		<title level="j">Emerg Microbes Infect</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="313" to="332" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">A pneumonia outbreak associated with a new coronavirus of probable bat origin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><forename type="middle">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><forename type="middle">G</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41586-020-2012-7</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<date type="published" when="2020-02-03" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">T</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Leung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename><surname>Leung</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(20)30260-9</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="page" from="30260" to="30269" />
			<date type="published" when="2020-01-31" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travelers from Wuhan, China</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Backer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Klinkenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Wallinga</surname></persName>
		</author>
		<idno type="DOI">10.2807/1560-7917.ES.2020.25.5.2000062</idno>
	</analytic>
	<monogr>
		<title level="j">Euro Surveill</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="20" to="28" />
			<date type="published" when="2020-01" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Shu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">Z</forename><surname>Hua</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">B</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12519-020-00345-5</idno>
		<idno>doi: 10.1007/ s12519-020-00345-5</idno>
	</analytic>
	<monogr>
		<title level="j">World J Pediatr</title>
		<imprint>
			<date type="published" when="2020-02-05" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Epidemiological characteristics of 2019 novel coronavirus: an interim review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">C</forename><surname>Chun</surname></persName>
		</author>
		<idno type="DOI">10.4178/epih.e2020006</idno>
	</analytic>
	<monogr>
		<title level="j">Epidemiol Health</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page">6</biblScope>
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">CT imaging features of 2019 novel coronavirus (2019-nCoV)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Bernheim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Mei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Zeng</surname></persName>
		</author>
		<idno type="DOI">10.1148/radiol.2020200230</idno>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<date type="published" when="2020-02-04" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Kanne</surname></persName>
		</author>
		<idno type="DOI">10.1148/radiol.2020200241</idno>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<date type="published" when="2020-02-04" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Emerging coronavirus 2019-nCoV pneumonia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Shan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Lu</surname></persName>
		</author>
		<idno type="DOI">10.1148/radiol.2020200274</idno>
		<idno>doi: 10.1148/ radiol.2020200274</idno>
	</analytic>
	<monogr>
		<title level="j">Radiology</title>
		<imprint>
			<date type="published" when="2020-02-06" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">Drug treatment options for the 2019-new coronavirus (2019-nCoV)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Lu</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title/>
		<idno type="DOI">10.5582/bst.2020.01020</idno>
	</analytic>
	<monogr>
		<title level="j">Biosci Trends</title>
		<imprint>
			<date type="published" when="2020-01-28" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41422-020-0282-0</idno>
		<idno>doi: 10.1038/ s41422-020-0282-0</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Res</title>
		<imprint>
			<date type="published" when="2020-02-04" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Morse</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Lalonde</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1002/cbic.202000047</idno>
		<idno>doi: 10.1002/ cbic.2020 0 0 047</idno>
	</analytic>
	<monogr>
		<title level="j">Chembiochem</title>
		<imprint>
			<date type="published" when="2020-02-05" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Rolain</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Colson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Raoult</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijantimicag.2007.05.015</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Antimicrob Agents</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="297" to="308" />
			<date type="published" when="2007" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Wei</surname></persName>
		</author>
		<idno type="DOI">10.1002/jmv.25689</idno>
	</analytic>
	<monogr>
		<title level="j">China. J Med Virol</title>
		<imprint>
			<date type="published" when="2020-01-29" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">G</forename><surname>Choe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">J</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Park</surname></persName>
		</author>
		<idno type="DOI">10.3346/jkms.2020.35.e61</idno>
	</analytic>
	<monogr>
		<title level="j">J Korean Med Sci</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page">61</biblScope>
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<title level="m" type="main">World Health Organization (WHO)</title>
		<ptr target="https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200207-sitrep-18-ncov.pdf?sfvrsn=fa644293_2" />
		<imprint>
			<date type="published" when="2020-02-09" />
		</imprint>
	</monogr>
	<note>Situation report</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak-United States</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Db2019-Ncov Cdc Response</forename><surname>Jernigan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Team</surname></persName>
		</author>
		<idno type="DOI">10.15585/mmwr.mm6905e1</idno>
	</analytic>
	<monogr>
		<title level="j">MMWR Morb Mortal Wkly Rep</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="140" to="146" />
			<date type="published" when="2019-12-31" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Effects of air temperature and relative humidity on coronavirus survival on surfaces</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Casanova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Jeon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">A</forename><surname>Rutala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Sobsey</surname></persName>
		</author>
		<idno type="DOI">10.1128/AEM.02291-09</idno>
	</analytic>
	<monogr>
		<title level="j">Appl Environ Microbiol</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="2712" to="2729" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Kampf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Todt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Pfaeder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Steinmann</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jhin.2020.01.022</idno>
	</analytic>
	<monogr>
		<title level="j">J Hosp Infect</title>
		<imprint>
			<date type="published" when="2020-02-06" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title level="m" type="main">Clinical characteristics of 2019 novel coronavirus infection in China</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">J</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><forename type="middle">Y</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">H</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">Q</forename><surname>Ou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">X</forename><surname>He</surname></persName>
		</author>
		<idno type="DOI">10.1101/2020.02.06.20020974</idno>
		<idno>doi: 10.1101/ 2020.02.06</idno>
		<imprint>
			<date type="published" when="2020-02-09" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Coronavirus infections and immune responses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Zhou</surname></persName>
		</author>
		<idno type="DOI">10.1002/jmv.25685</idno>
	</analytic>
	<monogr>
		<title level="j">J Med Virol</title>
		<imprint>
			<date type="published" when="2020-01-25" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">D</forename><surname>Russell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">E</forename><surname>Millar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">K</forename><surname>Baillie</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(20)30317-2</idno>
		<idno>doi: 10. 1016/S0140-6736(20</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">395</biblScope>
			<biblScope unit="page" from="30317" to="30319" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
